Silvercrest Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,005
Closed -$575K 881
2026
Q1
$575K Sell
11,005
-331
-3% -$19.9K ﹤0.01% 668
2025
Q4
$667K Buy
11,336
+222
+2% +$13.5K ﹤0.01% 669
2025
Q3
$618K Buy
11,114
+224
+2% +$12K ﹤0.01% 673
2025
Q2
$560K Buy
10,890
+2,044
+23% +$103K ﹤0.01% 697
2025
Q1
$519K Buy
8,846
+770
+10% +$52.2K ﹤0.01% 694
2024
Q4
$582K Buy
8,076
+687
+9% +$50.4K ﹤0.01% 669
2024
Q3
$591K Buy
7,389
+77
+1% +$5.79K ﹤0.01% 627
2024
Q2
$524K Buy
7,312
+108
+1% +$7.95K ﹤0.01% 712
2024
Q1
$507K Buy
7,204
+1,600
+29% +$114K ﹤0.01% 703
2023
Q4
$432K Buy
5,604
+1,957
+54% +$129K ﹤0.01% 692
2023
Q3
$248K Sell
3,647
-1,124
-24% -$88.8K ﹤0.01% 774
2023
Q2
$389K Buy
4,771
+945
+25% +$76K ﹤0.01% 711
2023
Q1
$284K Sell
3,826
-12,994
-77% -$1M ﹤0.01% 728
2022
Q4
$1.39M Sell
16,820
-508
-3% -$40.3K 0.01% 524
2022
Q3
$1.23M Buy
17,328
+6,788
+64% +$587K 0.01% 526
2022
Q2
$913K Buy
10,540
+7,648
+264% +$717K 0.01% 579
2022
Q1
$313K Buy
2,892
+172
+6% +$17.7K ﹤0.01% 758
2021
Q4
$352K Buy
2,720
+240
+10% +$29.4K ﹤0.01% 722
2021
Q3
$300K Sell
2,480
-252
-9% -$30.7K ﹤0.01% 754
2021
Q2
$308K Sell
2,732
-1,032
-27% -$109K ﹤0.01% 750
2021
Q1
$359K Sell
3,764
-1,160
-24% -$106K ﹤0.01% 722
2020
Q4
$391K Buy
+4,924
New +$357K ﹤0.01% 668

Other funds holding TECH

Silvercrest Asset Management's TECH Position: Q2 2026 in Review

Silvercrest Asset Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 11,005 shares — an estimated $575K sold.

Silvercrest Asset Management first reported a position in TECH in Q4 2020 and held it in 22 quarters. The position peaked at $1.39M in Q4 2022. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Silvercrest Asset Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Silvercrest Asset Management sold 11,005 Bio-Techne shares in Q2 2026, an estimated $575K.
  • Silvercrest Asset Management first reported a position in Bio-Techne in Q4 2020 and held it in 22 quarters.
  • Silvercrest Asset Management's Bio-Techne position peaked at $1.39M in Q4 2022.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.